Inhibition of SRC-2 or select SRC-2 target genes accelerated proliferation of human liver cancer cells in vitro and tumorigenesis in vivo, while overexpression of SRC-2 targets, or SRC-2 itself, resulted in tumor suppressive effects. The gene discussed is NCOA2; the disease is liver cancer.